|1|Impact of fatty acid oxidation disorders in child neurology: from Reye syndrome to Pandora's box. (25761966)
|2|Should the beneficial impact of bezafibrate on fatty acid oxidation disorders be questioned? (25310995)
Bastin J.... Bresson J.L.
|3|Bezafibrate in skeletal muscle fatty acid oxidation disorders: a randomized clinical trial. (24453079)
A9rngreen M.C.... LaforA-t P.
|4|Muscle MRI in patients with long-chain fatty acid oxidation disorders. (24305961)
Diekman E.F.... Visser G.
|5|The effect of valinomycin in fibroblasts from patients with fatty acid oxidation disorders. (23867825)
Ndukwe Erlingsson U.C.... Longo N.
|6|Neuropsychological outcomes in fatty acid oxidation disorders: 85 cases detected by newborn screening. (23798014)
Waisbren S.E.... Vockley J.
|7|Pathophysiology of fatty acid oxidation disorders and resultant phenotypic variability. (23674167)
|8|Clinical study of organic acidemias and fatty acid oxidation disorders detected in adults. (23524598)
Yamada K.... Yamaguchi S.
|9|Variability in the clinical management of fatty acid oxidation disorders: results of a survey of Canadian metabolic physicians. (21630065)
Potter B.K.... Wilson B.J.
|10|Bezafibrate can be a new treatment option for mitochondrial fatty acid oxidation disorders: evaluation by in vitro probe acylcarnitine assay. (22841441)
Yamaguchi S.... Fukuda S.
|11|Fatty acid omega-oxidation as a rescue pathway for fatty acid oxidation disorders in humans. (21156023)
Wanders R.J.... Kemp S.
|12|Mitochondrial fatty acid oxidation disorders. Proceedings of an international symposium. October 2008. Fulda, Germany. (21275107) |2010|
|13|Update on mitochondrial fatty acid oxidation disorders. (20842433)
Spiekerkoetter U.... Mayatepek E.
|14|Fatty acid oxidation disorders: outcome and long-term prognosis. (20049534)
|15|Fatty acid oxidation disorders: maternal health and neonatal outcomes. (19926542)
Rector R.S.... Ibdah J.A.
|16|Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening. (20449660)
|17|Current issues regarding treatment of mitochondrial fatty acid oxidation disorders. (20830526)
Spiekerkoetter U.... Wilcken B.
|18|Mitochondrial fatty acid oxidation disorders: pathophysiological studies in mouse models. (20532823)
Spiekerkoetter U.... Wood P.A.
|19|PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders. (18392740)
Djouadi F.... Bastin J.
|20|Mitochondrial fatty-acid oxidation disorders. (18708005)
Kompare M.... Rizzo W.B.
|21|Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts. (16297647)
Roe D.S.... Roe C.R.
|22|Fatty acid oxidation disorder as a cause of sudden infant death syndrome (SIDS)--a case report. (16366103)
Thanka J.... Kuruvilla S.
|23|The association between acute fatty liver of pregnancy and fatty acid oxidation disorders. (15673650)
|24|Identification of fatty acid oxidation disorder patients with lowered acyl-CoA thioesterase activity in human skin fibroblasts. (15638818)
Hunt M.C.... Wanders R.J.
|25|Implications of impaired ketogenesis in fatty acid oxidation disorders. (14769488)
|26|Mitochondrial trifunctional protein deficiency: a severe fatty acid oxidation disorder with cardiac and neurologic involvement. (12838198)
den Boer M.E.... Wijburg F.A.
|27|Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases. (12582009)
Shekhawat P.... Strauss A.W.
|28|A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiency. (12385891)
Okun J.G.... Mayatepek E.
|29|Management of fatty acid oxidation disorders: a survey of current treatment strategies. (12487544)
Solis J.O.... Singh R.H.
|30|Mitochondrial fatty acid oxidation disorders in Thai infants: a report of 3 cases. (12403251)
Wasant P.... Liammongkolkul S.
|31|Incidence and short-term outcome of children with symptomatic presentation of organic acid and fatty acid oxidation disorders in Germany. (12456920)
Klose D.A.... Hoffmann G.F.
|32|Peroxisomal fatty acid oxidation disorders and 58 kDa sterol carrier protein X (SCPx). Activity measurements in liver and fibroblasts using a newly developed method. (10706581)
Ferdinandusse S.... Wanders R.J.
|33|Prevalent mutations in fatty acid oxidation disorders: diagnostic considerations. (11216903)
Gregersen N.... Bross P.
|34|Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders. (10682306)
Shen J.J.... Van Hove J.L.
|35|Improving the outcome for fatty acid oxidation disorders. (11045831)
Morris A.A.... Leonard J.V.
|36|Mitochondrial fatty acid oxidation disorders and cyclic vomiting syndrome. (10490047)
|37|A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. (10377439)
Leone T.C.... Kelly D.P.
|38|Sudden and unexpected neonatal death: a protocol for the postmortem diagnosis of fatty acid oxidation disorders. (10331471)
Rinaldo P.... Giordano G.
|39|Neonatal onset in fatty acid oxidation disorders: how can we minimize morbidity and mortality? (9762596)
|40|Analysis of carnitine esters by radio-high performance liquid chromatography in cultured skin fibroblasts from patients with mitochondrial fatty acid oxidation disorders. (9702916)
Schmidt-Sommerfeld E.... Bennett M.J.
|41|Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life. (9627580)
Boles R.G.... Rinaldo P.
|42|Fatty acid oxidation disorders as primary cause of sudden and unexpected death in infants and young children: an investigation performed on cultured fibroblasts from 79 children who died aged between 0-4 years. (9350306)
Lundemose J.B.... Gregersen M.
|43|In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique. (9266222)
Jakobs C.... Saudubray J.M.
|44|Identification and quantification of intermediates of unsaturated fatty acid metabolism in plasma of patients with fatty acid oxidation disorders. (7586519)
Onkenhout W.... Poorthuis B.J.
|45|Rapid diagnosis of long chain and medium chain fatty acid oxidation disorders using lymphocytes. (7785942)
Brivet M.... Lemonnier A.
|46|Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a severe fatty acid oxidation disorder. (7813533)
Sewell A.C.... Wanders R.J.
|47|Biochemical diagnosis of fatty acid oxidation disorders by metabolite analysis of postmortem liver. (8056418)
Boles R.G.... Rinaldo P.
|48|The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders. (1438380)
Millington D.S.... Roe C.R.
|49|Fatty acid oxidation disorders: a new class of metabolic diseases. (1625065)
Hale D.E.... Bennett M.J.
|50|Postmortem recognition of fatty acid oxidation disorders. (1866359)
Bennett M.J.... Stanley C.A.